KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

Synthetic products posing as kratom mislead and endanger consumers; AKA urges FDA to take decisive action against violative ...